Featured Research

from universities, journals, and other organizations

Diverticulosis much less risky than previously thought, study suggests

Date:
December 3, 2013
Source:
University of California, Los Angeles (UCLA), Health Sciences
Summary:
People who have diverticulosis, or pouches in the lining of the colon, often worry that they will eventually develop a painful and sometimes serious condition called diverticulitis, as previous research has shown that one in four, or up to 25 percent, of those with the condition will.

People who have diverticulosis, or pouches in the lining of the colon, often worry that they will eventually develop a painful and sometimes serious condition called diverticulitis, as previous research has shown that one in four, or up to 25 percent, of those with the condition will.

Now, in a 15-year study that contradicts the common wisdom on rate of progression from diverticulosis to diverticulitis, UCLA researchers show that the risk is significantly lower than previously thought, about 1 percent over seven years. Researchers also found that those diagnosed with diverticulosis at a younger age are more likely to progress to diverticulitis than those diagnosed at an older age.

The study will help inform patients with diverticulosis -- particularly those diagnosed at a younger age -- and their physicians about the risks of developing acute diverticulitis, said study senior author Dr. Brennan Spiegel, an associate professor of medicine at the David Geffen School of Medicine at UCLA.

"These colon pouches are commonly detected during colonoscopy, and patients wonder if they are important and what to do with them," Spiegel said. "In short, diverticulosis is not something to worry much about. Chances are low that something will happen."

The study appears in the December edition of the peer-reviewed journal Clinical Gastroenterology and Hepatology.

As they age, most people develop diverticulosis. More than half of people over 60 and two-thirds of those over 70 have the condition, but the pouches usually don't cause any problems. Occasionally, the pouches become inflamed, leading to diverticulitis, which causes pain and infection in the abdomen. Doctors usually treat the condition with antibiotics, or in more severe cases, surgery.

Spiegel said the research predicting that one in four patients with diverticulosis would develop diverticulitis is based on limited data pulled from a time when population-based colonoscopy was not performed.

"These risk figures have been widely quoted throughout the literature and appear in multiple research publications, prominent review articles, textbooks and public guidelines," Spiegel said. "Because the data are from before the advent of routine colonoscopy, many cases of diverticulosis may have gone undiscovered, skewing the risk predictions."

The retrospective UCLA study identified 2,222 patients from the Veterans Affairs Health System with chart-confirmed diverticulosis and followed them over a median of 6.75 years. Of those 2,222 patients, 95 patients, or 4.3 percent, developed diverticulitis using a liberal definition of the condition not requiring CT scan confirmation. Of those 95, 23 patients, or only 1 percent, developed diverticulitis that met a very rigorous definition of the condition requiring CT scan or surgery to confirm the diagnosis.

And although the younger patients were more likely to develop diverticulitis, their risk was nowhere near the traditionally-cited 25 percent level, Spiegel said.

"With an aging population and greater use of colonoscopy for colorectal cancer screening, more and more people are going to be told they have diverticulosis," Spiegel said. "Patients often question the significance of this. If providers had more accurate information regarding the risk of diverticulosis complications, they then could make better decisions about the timing of interventions such as surgery."

Spiegel said the study had limitations. It was a retrospective, single-center study in a Veterans Affairs hospital where the patients were primarily Western and predominantly male. Also, the researchers relied on administrative data to identify diverticulitis cases, and some cases may have been missed. However, the team did perform extensive reviews of medical records to confirm the chart evidence of diverticulitis.

Going forward, Spiegel and his team will study diverticulosis in other, more diverse populations to confirm these findings.

Diverticular disease accounts for more than 300,000 hospital admissions, 1.5 million inpatient care days and $2.4 billion in direct costs annually in the United States.

"These data may help to re-frame discussions with patients regarding their probability of developing clinically significant diverticulitis," the study states. "Future research should identify individual predictors of diverticulitis in a prospective analysis to better risk-stratify among patients and further study why younger patients may harbor a higher risk of progression than do older patients."


Story Source:

The above story is based on materials provided by University of California, Los Angeles (UCLA), Health Sciences. Note: Materials may be edited for content and length.


Journal Reference:

  1. Kamyar Shahedi, Garth Fuller, Roger Bolus, Erica Cohen, Michelle Vu, Rena Shah, Nikhil Agarwal, Marc Kaneshiro, Mary Atia, Victoria Sheen, Nicole Kurzbard, Martijn G.H. van Oijen, Linnette Yen, Paul Hodgkins, M. Haim Erder, Brennan Spiegel. Long-term Risk of Acute Diverticulitis Among Patients With Incidental Diverticulosis Found During Colonoscopy. Clinical Gastroenterology and Hepatology, 2013; 11 (12): 1609 DOI: 10.1016/j.cgh.2013.06.020

Cite This Page:

University of California, Los Angeles (UCLA), Health Sciences. "Diverticulosis much less risky than previously thought, study suggests." ScienceDaily. ScienceDaily, 3 December 2013. <www.sciencedaily.com/releases/2013/12/131203090530.htm>.
University of California, Los Angeles (UCLA), Health Sciences. (2013, December 3). Diverticulosis much less risky than previously thought, study suggests. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/12/131203090530.htm
University of California, Los Angeles (UCLA), Health Sciences. "Diverticulosis much less risky than previously thought, study suggests." ScienceDaily. www.sciencedaily.com/releases/2013/12/131203090530.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins